Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | GEHC | Common Stock, par value $0.01 per share | Award | $0 | +6.25K | +10.69% | $0.00 | 64.7K | Feb 1, 2023 | Direct | F1, F2, F3 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | GEHC | Employee Stock Option (right to buy) | Award | +54.9K | 54.9K | Feb 1, 2023 | Common Stock, par value $0.01 per share | 54.9K | $70.01 | Direct | F4 |
Id | Content |
---|---|
F1 | Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 50% will vest on February 1, 2025 and 50% will vest on February 1, 2026. |
F2 | Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. |
F3 | The reporting person has reported prior awards of restricted stock units in Table II of Form 4. The total reported in Column 5 includes 6,249 newly awarded restricted stock units, 58,274 previously reported restricted stock units, and 185 shares of common stock. |
F4 | Award of an employee stock option with respect to GE HealthCare common stock, of which 50% will become exercisable on February 1, 2025 and 50% will become exercisable on February 1, 2026. |